NO20043209L - Fremstilling av A9 tetrahydrocannabinol - Google Patents

Fremstilling av A9 tetrahydrocannabinol

Info

Publication number
NO20043209L
NO20043209L NO20043209A NO20043209A NO20043209L NO 20043209 L NO20043209 L NO 20043209L NO 20043209 A NO20043209 A NO 20043209A NO 20043209 A NO20043209 A NO 20043209A NO 20043209 L NO20043209 L NO 20043209L
Authority
NO
Norway
Prior art keywords
acid
thc
converted
tetrahydrocannabinol
preparation
Prior art date
Application number
NO20043209A
Other languages
English (en)
Norwegian (no)
Inventor
Alan Kenneth Greenwood
Neil John Goodwin
Nicolas James Archer
Christopher Murray
Derek Machattie
Original Assignee
Resolution Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0202396A external-priority patent/GB0202396D0/en
Application filed by Resolution Chemicals Ltd filed Critical Resolution Chemicals Ltd
Publication of NO20043209L publication Critical patent/NO20043209L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
  • Optical Integrated Circuits (AREA)
  • Pyrane Compounds (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Steroid Compounds (AREA)
NO20043209A 2002-02-01 2004-07-28 Fremstilling av A9 tetrahydrocannabinol NO20043209L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0202396A GB0202396D0 (en) 2002-02-01 2002-02-01 Production of delta 9 tetrahydrocannabinol
GB0214022A GB0214022D0 (en) 2002-02-01 2002-06-18 Production of delta 9 tetrahydrocannabinol
PCT/GB2003/000441 WO2003064407A2 (en) 2002-02-01 2003-02-03 Production of δ9 tetrahydrocannabinol

Publications (1)

Publication Number Publication Date
NO20043209L true NO20043209L (no) 2004-10-28

Family

ID=27665366

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043209A NO20043209L (no) 2002-02-01 2004-07-28 Fremstilling av A9 tetrahydrocannabinol

Country Status (17)

Country Link
US (3) US7524881B2 (pt)
EP (2) EP1474412B1 (pt)
JP (1) JP2005526715A (pt)
CN (2) CN1642934A (pt)
AT (1) ATE396984T1 (pt)
AU (2) AU2003205844B2 (pt)
BR (1) BR0307330A (pt)
CA (1) CA2474951A1 (pt)
DE (2) DE60321318D1 (pt)
DK (1) DK1474412T3 (pt)
ES (1) ES2305437T3 (pt)
NO (1) NO20043209L (pt)
NZ (2) NZ552547A (pt)
PT (1) PT1474412E (pt)
SI (1) SI1474412T1 (pt)
WO (1) WO2003064407A2 (pt)
ZA (1) ZA200405938B (pt)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005526715A (ja) * 2002-02-01 2005-09-08 レゾリューション ケミカルズ リミテッド Δ９−テトラヒドロカンナビノールの製造
GB2391865B (en) * 2002-08-14 2005-06-01 Gw Pharma Ltd Improvements in the extraction of pharmaceutically active components from plant materials
ES2392510T3 (es) * 2002-08-14 2012-12-11 Gw Pharma Limited Extracción de canabinoides farmacéuticamente activos de materiales vegetales
GB2408978B (en) * 2002-09-23 2006-04-05 Gw Pharma Ltd Methods of preparing delta-9 tetrahydrocannabinol from plant material
GB0222077D0 (en) 2002-09-23 2002-10-30 Gw Pharma Ltd Methods of preparing cannabinoids from plant material
TWI436991B (zh) * 2004-11-22 2014-05-11 Euro Celtique Sa 用於純化反-（-）-△９-四氫大麻酚與反-（＋）-△９-四氫大麻酚之方法
EP1827393A4 (en) * 2004-12-09 2012-04-18 Insys Therapeutics Inc DRONABINOL FORMULATIONS WITH LABORATORY TEMPERATURE
TWI366460B (en) * 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
NZ567029A (en) * 2005-09-29 2011-09-30 Amr Technology Inc Process for production of delta-9- tetrahydrocannabinol
US20080112895A1 (en) * 2006-08-04 2008-05-15 Insys Therapeutics Inc. Aqueous dronabinol formulations
US20080103193A1 (en) * 2006-10-26 2008-05-01 Trevor Percival Castor Methods for making compositions and compositions for treating pain and cachexia
GB0703284D0 (en) 2007-02-20 2007-03-28 Resolution Chemicals Ltd Delta 9 - tetrahydrocannabinol processing
US20090181080A1 (en) * 2007-08-06 2009-07-16 Insys Therapeutics Inc. Oral cannabinnoid liquid formulations and methods of treatment
US20090042974A1 (en) * 2007-08-07 2009-02-12 Anson David Parker Compositions And Methods Relating To Extensible Transgenic Vector Assembler, Pestilence Ridder, Plus Cannabinoid Producer
GB0807915D0 (en) * 2008-05-01 2008-06-04 Resolution Chemicals Ltd Production of delta 9 tetrahydrocannabinol
US8343553B2 (en) 2011-04-18 2013-01-01 Hospodor Andrew D Essential element extractor
EP2760444B1 (de) * 2011-09-29 2020-04-22 THC Pharm GmbH The Health Concept Cannabinoidcarbonsäuren, salze von cannabinoidcarbonsäuren, deren herstellung und anwendungen
US9358259B2 (en) 2012-03-20 2016-06-07 Andrew David Hospodor Recycling cannabinoid extractor
SI2844243T1 (sl) * 2012-05-03 2020-02-28 Echo Pharmaceuticals B.V. Metoda za pripravo izolata iz rastline konoplje, ki obsega delta-9-tetrahidrokanabinol
US20130337052A1 (en) * 2012-06-19 2013-12-19 Patricia Linert System and Method of Reducing Impairment of Alertness, Concentration, Motivation, and Creativity Caused by Medication
US9155767B2 (en) 2012-10-18 2015-10-13 Andrew D. Hospodor Essential element management
EP2968259B1 (en) 2013-03-14 2022-09-14 SC Laboratories Inc. Bioactive concentrates and uses thereof
US9199960B2 (en) * 2013-05-02 2015-12-01 Frederick R. Ferri Method and apparatus for processing herbaceous plant materials including the cannabis plant
US9220294B2 (en) 2014-02-11 2015-12-29 Timothy McCullough Methods and devices using cannabis vapors
US10821240B2 (en) 2014-02-11 2020-11-03 Vapor Cartridge Technology Llc Methods and drug delivery devices using cannabis
US9380813B2 (en) 2014-02-11 2016-07-05 Timothy McCullough Drug delivery system and method
US20170312327A1 (en) * 2014-11-17 2017-11-02 Connoisseur Holdings, Llc Extraction devices, systems, and methods
PT3247371T (pt) * 2015-01-22 2020-07-02 Phytoplant Res S L Métodos de purificação de canabinóides, composições e kits associados
US10207198B2 (en) * 2015-01-22 2019-02-19 Phytoplant Research S.L. Methods of purifying cannabinoids using liquid:liquid chromatography
US11034639B2 (en) 2015-01-22 2021-06-15 Phytoplant Research S.L. Methods of purifying cannabinoids using liquid:liquid chromatography
US11040295B2 (en) 2015-02-06 2021-06-22 Joseph Francis Payack Method and apparatus for extracting plant oils using ethanol water
MA42057A (fr) 2015-05-07 2018-03-14 Axim Biotechnologies Inc Procédé d'extraction et de purification de delta-9-tétrahydrocannabinol
US10913071B2 (en) 2016-03-09 2021-02-09 Pearson Incorporated Scalper apparatus and processing system
US10499584B2 (en) 2016-05-27 2019-12-10 New West Genetics Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
WO2018000094A1 (en) 2016-06-29 2018-01-04 CannScience Innovations Inc. Decarboxylated cannabis resins, uses thereof and methods of making same
US10322487B1 (en) 2016-07-15 2019-06-18 Pearson Incorporated Roller mill grinding apparatus with regenerative capability
EP3484459A4 (en) * 2016-07-15 2020-03-11 S.S. Steiner, Inc. DECARBOXYLATION OF CANNABIDIOLIC ACID IN HEMP BIOMASS AND HANE EXTRACT
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
US10807098B1 (en) 2017-07-26 2020-10-20 Pearson Incorporated Systems and methods for step grinding
IT201700085508A1 (it) * 2017-07-26 2019-01-26 Inalco S R L Metodo per la produzione di cannabinoidi da varietà di canapa industriale
US10272360B2 (en) 2017-08-05 2019-04-30 Priya Naturals, Inc. Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
US10406453B2 (en) * 2017-09-29 2019-09-10 NextLeaf Solutions Ltd. Cannabinoid extraction process using brine
US10941102B2 (en) * 2017-11-29 2021-03-09 Robert Henry Wohleb Aqueous leaching method to produce microcrystalline powder
CN111788171A (zh) * 2018-01-29 2020-10-16 菲拓普兰特研究公司 使用液：液色谱法纯化大麻素的方法
US11202771B2 (en) 2018-01-31 2021-12-21 Treehouse Biotech, Inc. Hemp powder
US11325133B1 (en) 2018-07-26 2022-05-10 Pearson Incorporated Systems and methods for monitoring the roll diameter and shock loads in a milling apparatus
WO2020060959A1 (en) * 2018-09-17 2020-03-26 Sorbent Technologies, Inc. Methods for removing contaminants from plant-derived pharmaceuticals
CA3119729A1 (en) 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
US10751722B1 (en) 2018-10-24 2020-08-25 Pearson Incorporated System for processing cannabis crop materials
US20220079880A1 (en) * 2019-01-17 2022-03-17 Thomas Piccariello Solid micellar compositions of cannabinoid acids
US10785906B2 (en) 2019-02-19 2020-09-29 Pearson Incorporated Plant processing system
AU2020247619A1 (en) * 2019-03-24 2021-11-11 Omega Life Science Ltd. Electronic cigarettes
WO2020210119A1 (en) 2019-04-11 2020-10-15 Mantrose-Haeuser Co., Inc. Cannabis delivery with protective glaze coating
US11370767B2 (en) 2019-04-23 2022-06-28 Soma Oil Llc Cannabis processing systems and methods
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia
MX2022003189A (es) 2019-09-16 2022-06-08 Vapor Cartridge Tech Llc Sistema de administración de fármacos con sustratos apilables.
US10757860B1 (en) 2019-10-31 2020-09-01 Hemp Processing Solutions, LLC Stripper apparatus crop harvesting system
US10933424B1 (en) 2019-12-11 2021-03-02 Pearson Incorporated Grinding roll improvements
CN111039760A (zh) * 2019-12-16 2020-04-21 福建省中科生物股份有限公司 一种制备酚类化合物的方法
US11351476B2 (en) * 2020-01-07 2022-06-07 Agrify Corporation Method for chemical separation of cannabinoids
WO2021248235A1 (en) * 2020-06-09 2021-12-16 Protonify Corporation Process for isolation and purification of thca from cannabis
EP4208274A1 (en) 2020-09-04 2023-07-12 Herbolea Biotech S.p.A. Thc-free cannabinoid concentrate, method of obtaining the same and use thereof
US11242328B1 (en) * 2021-02-25 2022-02-08 Acid Neutral Alkaline Laboratory Heterogeneous catalyst and method for preparation of aromatic tricyclic pyrans
US11352337B1 (en) * 2021-06-02 2022-06-07 Acid Neutral Alkaline Laboratory Zeolite catalyst and method for preparation of aromatic tricyclic pyrans
CN115260005B (zh) * 2022-08-30 2024-01-30 晨光生物科技集团股份有限公司 一种纯化提取大麻二酚的方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342971A (en) * 1992-12-29 1994-08-30 The Australian National University Process for the preparation of dibenzo[b,d]pyrans
CA2220223C (en) 1995-05-05 2008-07-29 Hauser Inc. High purity carnosic acid from rosemary and sage extracts by ph-controlled precipitation
GB9726916D0 (en) * 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
US6730519B2 (en) * 1998-10-26 2004-05-04 The University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol
US6365416B1 (en) 1998-10-26 2002-04-02 The University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol
JP2005526715A (ja) 2002-02-01 2005-09-08 レゾリューション ケミカルズ リミテッド Δ９−テトラヒドロカンナビノールの製造

Also Published As

Publication number Publication date
JP2005526715A (ja) 2005-09-08
BR0307330A (pt) 2004-12-07
DE60321318D1 (de) 2008-07-10
US20090253783A1 (en) 2009-10-08
EP1803717A3 (en) 2007-07-11
ZA200405938B (pt) 2006-05-31
US7524881B2 (en) 2009-04-28
DE60332776D1 (de) 2010-07-08
CN100999513A (zh) 2007-07-18
US20050171361A1 (en) 2005-08-04
DK1474412T3 (da) 2008-09-01
WO2003064407A3 (en) 2003-10-16
EP1474412A2 (en) 2004-11-10
NZ552547A (en) 2008-03-28
US7592468B2 (en) 2009-09-22
SI1474412T1 (sl) 2008-10-31
ATE396984T1 (de) 2008-06-15
AU2003205844B2 (en) 2006-10-12
NZ534430A (en) 2007-09-28
US20050049298A1 (en) 2005-03-03
EP1474412B1 (en) 2008-05-28
PT1474412E (pt) 2008-07-04
CA2474951A1 (en) 2003-08-07
AU2006252300B2 (en) 2009-02-12
WO2003064407A2 (en) 2003-08-07
AU2006252300A1 (en) 2007-01-25
ES2305437T3 (es) 2008-11-01
EP1803717A2 (en) 2007-07-04
EP1803717B1 (en) 2010-05-26
CN1642934A (zh) 2005-07-20

Similar Documents

Publication Publication Date Title
NO20043209L (no) Fremstilling av A9 tetrahydrocannabinol
NO20062092L (no) Nye fremgangsmater for fremstilling av N-desmetylzopiklon og optisk rent (+)-N-desmetylzopiklon og optisk rent (-)-N-desmetylzopiklon
BRPI0315296B8 (pt) derivados do ciclohexanol espirocíclicos, medicamento incluindo pelo menos um derivado do ciclohexano espirocíclico e uso de um derivado do ciclohexano espirocíclico
BR0312729A (pt) Novos derivados de indol-3-enxofre
BR0312695A (pt) Derivados de 1h-pirrolidina-2,4-diona espirocìclicos substituìdos por cis-alcóxi
ECSP056016A (es) Nuevos derivados de 2-piridinacarboxamida
NO20051038L (no) Nye effektorkonjugater, fremgangsmate for deres fremstilling, og deres farmasoytiske bruk
PT1133283E (pt) Um metodo de producao de particulas de farmaco
WO2001089571A3 (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
ATE252571T1 (de) Tocotrienole und geranylgeraniol aus nebenprodukten von bixa orellana
UY26133A1 (es) Derivado sustituido de pirazol.
EA200200096A1 (ru) Новые производные витамина d с циклическими субструктурами в боковых цепях, способ и промежуточные продукты для их получения и их применение для получения лекарственных средств
AR029795A1 (es) Derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico sustituidos, procedimientos para su preparacion, su uso para la preparacion de medicamentos y medicamentos que contienen estos compuestos
UY26951A1 (es) Derivados de ácido propiónico
ES2187483T3 (es) Procedimiento para la preparacion de acido a-lipoico esento de disolvente.
WO2003029391A1 (fr) Procede de production de compositions de matiere grasse renfermant de l'acide oleanolique et/ou de l'acide maslinique
BR0309357A (pt) Método para fabricar cristais de esteróides, cristais obtìveis de acordo com esse método, e formulações farmacêuticas
IT1319195B1 (it) Processo per la produzione dell'acido r(+)alfa-lipoico.
NO20052329L (no) Fremgangsmate for rensingen av 1,4-butandiol-mononitrat
IL153830A0 (en) A PROCESS FOR THE PREPARATION OF alpha' CHLOROKETONES
EP1258478A4 (en) PROCESS FOR THE PREPARATION OF CHINOLONCARBOXYLIC ACIDS AND THEIR INTERMEDIATE PRODUCTS
BR0116918A (pt) Preparação de warfarin sódico a partir do ácido de warfarin
ES2146772T3 (es) Derivados de imidoacidos y su empleo como pesticidas.
BR0207953A (pt) Derivados de caloporosida, processos para a sua preparação e sua aplicação
DE60222945D1 (de) Verfahren zur herstellung von cefpodoxim-proxetil

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application